Tablets & Capsules March 2018 13
A
continuing debate for established, emerging, and
virtual biopharmaceutical companies is whether or not to
outsource production to a CMO. At its core, the issue is
about brand protection. While outsourcing can minimize
your capital and labor costs, it can be challenging to
evaluate CMOs and determine which one will best serve
your needs as a manufacturing partner.
Many factors influence the selection of a pharmaceutical
contract manufacturing organization (CMO) beyond the
price on the bid. This article discusses what to consider when
choosing a CMO to manufacture your drug product.
Choosing a contract manufacturing
organization
Christa Myers and
Kevin Debbs
CRB USA
outsourcing
